The Italian Registry for therapeutic apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology

Journal of Clinical Apheresis

Volumn 20, Issue 2, 2005, Pages 101-106

  Passalacqua, Stefano ^a   Staffolani, Emiliano ^a   Busnach, Ghil ^b   Roccatello, Dario ^c   Pasquali, Sonia ^d   Cappelli, Paolo ^e   Liuzzo, Gabriele ^f  

^a CATHOLIC UNIVERSITY   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c S GIOVANNI BOSCO HOSPITAL   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^f SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

Apheresis registry; Italy; Plasma exchange; Plasma treatment; Therapeutic apheresis

Indexed keywords

BILIRUBIN; CITRIC ACID; DEXTRAN SULFATE; HEPARIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN A;

ADSORPTION; APHERESIS; BLOOD FILTER; CONFERENCE PAPER; CRYOGLOBULINEMIA; CYTAPHERESIS; DATA ANALYSIS; DEVICE; FEMALE; FRACTIONATION; GUILLAIN BARRE SYNDROME; HEALTH CENTER; HEALTH SURVEY; HEMOFILTRATION; HUMAN; HYPOTENSION; IMMUNOADSORPTION; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYASTHENIA GRAVIS; NEPHROLOGY; OUTCOMES RESEARCH; PLASMAPHERESIS; PUVA; REGISTER; SYSTEMIC LUPUS ERYTHEMATOSUS; TECHNIQUE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION;

BLOOD COMPONENT REMOVAL; HUMANS; ITALY; NEPHROLOGY; REGISTRIES; SOCIETIES, MEDICAL;

EID: 24744466513     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.20037     Document Type: Conference Paper

References (13)

1. Busnach G, Passalacqua S, a nome del Gruppo di Studio Aferesi Terapeutica della Società Italiana di Nefrologia: Linee Guida per l'aferesi terapeutica in Nefrologia. Giornale It Nefrol 2000;17/4:433-439.
2. Stegmayr B, Korach JM, Norda R, Rock G, Fadel F. Is there a need for a national or a global apheresis registry? Transfus Apheresis Sci 2003;2:179-185.
3. Korach JM, Guillevin L, Petitpas D, Berger P, Chillet V. Apheresis Registry in France: indications, techniques, and complications. French Registry Study Group. Ther Apher 2000;4:207-210.
4. Norda R, Stegmayr BG. Apheresis Registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish Apheresis Study Group. Transfus Apheresis Sci 2001;24:49-55.
5. Clark WF, Rock GA, Buskard N, Shumak KH, LeBlond P, Anderson D, et al. Therapeutic plasma exchange: an update from the Canadian Apheresis Group. Ann Intern Med 1999;131:453-462.
6. Passalacqua S, Staffolani E. Registro Italiano per l'Aferesi terapeutica: primi 6 anni di attività. In: Cappelli P, Amoroso L, Di Liberato L, editors. Aferesi Terapeutica. Cosenza, Italy: Editoriale Bios, 2003. p 209-218.
7. De Silvestro G, Marson P, Russo GE, Vicarioto M, Donadel C. National survey of apheresis activity in Italy (2000). Transfus Apheresis Sci 2004;30:61-71.
8. Antozzi C, Berta E, Confalonieri P, Zuffi M, Cornelio F, Mantegazza R. Protein-A adsorption is effective in immunosuppression resistant myasthenia gravis. Lancet 1994;343:124.
9. Novelli G, Rossi M, Pretagostini R, Berloco P. A 3 years experience with MARS: our results on 63 patients with hepatic failure and color doppler US evaluation of cerebral perfusion. Liver Int 2003;S3:10-15.
10. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994;23:574-581.
11. Moriconi L, Passalacqua S, Pretagostini R, Battaglia G, Russo G, De Palo T, Rindi P, Puccini R, Batini V, Carraro M, Faccini L, Artero M, Zennaro C, Cristofani R. Apheresis in primary focal segmental glomerulosclerosis of native and transplanted kidneys: a therapeutic protocol. J Nephrol 2000;13:347-351.
12. Krebs A, Krebs K, Keller F. Retrospective comparison of 5 different methods for long-term LDL-apheresis in 20 patients between 1986 and 2001. Int J Artif Organs 2004;27:137-148.
13. Stefanutti C, Di Giacomo S, Vivenzio A, Isacchi GC, Masella R, Caprari P, Vari R, Tarzia A, Mosiello A, Cantafora A. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia. Clin Sci 2001;100:191-198.